Ares Commercial Real Estate Corp
F:41I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ares Commercial Real Estate Corp
F:41I
|
US |
|
T
|
Titanium Transportation Group Inc
F:I9V
|
CA |
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
O
|
OZ Minerals Ltd
F:OXR
|
AU |
|
J
|
Jacquet Metals SA
F:I43
|
FR |
|
R
|
Reservoir Media Inc
F:0RL0
|
US |
|
E
|
Endesa SA
XHAM:ENA
|
ES |
|
M
|
Medifast Inc
F:MDF
|
US |
|
H
|
Hanover Insurance Group Inc
F:AF4
|
US |
|
Staffline Group PLC
F:OSU
|
UK |
|
8
|
8x8 Inc
XMUN:EGT
|
US |
Wall St Price Targets
41I Price Targets Summary
Ares Commercial Real Estate Corp
According to Wall Street analysts, the average 1-year price target for
41I is 4.69 EUR with a low forecast of 4.42 EUR and a high forecast of 5.06 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41I's stock price target?
Price Target
4.69
EUR
According to Wall Street analysts, the average 1-year price target for
41I is 4.69 EUR with a low forecast of 4.42 EUR and a high forecast of 5.06 EUR.
What is the Revenue forecast for Ares Commercial Real Estate Corp?
Projected CAGR
-21%
Over the last 12 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is -21%.